Protein Kinase Inhibitors: all 15,766 studies that test it
Page 155 of 158. Open to participants first (2,605), then studies with results posted, then the rest; newest registration first within each.
- Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaCompletedNCT00087425Phase 2
- S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung CancerCompletedNCT00087412Phase 2
- Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal CancerTerminatedNCT00087334Phase 1/2
- Erlotinib in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer Undergoing Surgical ResectionTerminatedNCT00087269Phase 2
- CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal TumorCompletedNCT00087074Phase 2
- Docetaxel and Erlotinib in Treating Older Patients With Prostate CancerCompletedNCT00087035Phase 2
- Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma MultiformeCompletedNCT00086879Phase 2
- CCI-779 in Treating Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaTerminatedNCT00086840Phase 2
- Safety and Pharmacokinetics of XL647 Administered Orally to Subjects With Solid TumorsCompletedNCT00086528Phase 1
- Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED)CompletedNCT00086125Phase 2
- A Study of ARRY-142886 in Patients With Advanced CancerCompletedNCT00085787Phase 1
- Tipifarnib and Erlotinib Hydrochloride in Treating Patients With Advanced Solid TumorsCompletedNCT00085553Phase 1
- Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell FibroblastomaCompletedNCT00085475Phase 2
- Erlotinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerCompletedNCT00085280Not applicable
- CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic PhaseCompletedNCT00084916Phase 2
- Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008CompletedNCT00084825Phase 2
- Safingol and Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00084812Phase 1
- Gefitinib and Docetaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00084786Phase 1
- Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid TumorsCompletedNCT00084708Phase 1
- Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma ProtuberansCompletedNCT00084630Phase 2
- Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/Neu-Expressing CancerCompletedNCT00084513Phase 1
- N2001-03: CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk NeuroblastomaCompletedNCT00084422Phase 1
- Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast CancerTerminatedNCT00083993Phase 3
- Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and NeckCompletedNCT00083057Phase 1
- Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell NeoplasmsCompletedNCT00082784Phase 1
- Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the BreastTerminatedNCT00082667Phase 2
- Gleevec Trial in Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous LeukemiaCompletedNCT00081926Phase 4
- RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell LymphomaCompletedNCT00081874Phase 1/2
- A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell CarcinomaCompletedNCT00081614Phase 2
- Study of CEP-701 in Treatment of Prostate CancerCompletedNCT00081601Phase 2
- Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaCompletedNCT00081133Phase 1/2
- Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid TumorsCompletedNCT00080990Phase 1
- Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast CancerCompletedNCT00080743Phase 2
- Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone MetastasesCompletedNCT00080678Phase 2
- Docetaxel and Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Breast CancerCompletedNCT00080665Phase 1
- Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung CancerCompletedNCT00080340Phase 3
- Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer PatientsCompletedNCT00080197Phase 2
- Study of Nexavar (Sorafenib, BAY 43-9006) in Patients With Advanced Refractory CancerCompletedNCT00079612Phase 2
- Temsirolimus in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT00079456Phase 2
- Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT00079352Phase 1
- Imatinib (Gleevec(Registered Trademark)) to Treat Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous LeukemiaCompletedNCT00079313Phase 2
- CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung CancerCompletedNCT00079235Phase 2
- Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT00079053Phase 1
- Capecitabine (XELODA) With Or Without Lapatinib (GW572016) For Women With Refractory Advanced or Metastatic Breast CancerCompletedNCT00078572Phase 3
- A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.CompletedNCT00078000Phase 2
- Assessment Of Safety And Efficacy Of SU11248 In Patients With Metastatic Colorectal Cancer Who Have Failed Selected Previous Treatments.CompletedNCT00077987Phase 2
- Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid TumorsCompletedNCT00077454Phase 1
- Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or AnastrozoleStatus unknownNCT00077168Phase 2
- Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast CancerCompletedNCT00077025Phase 2
- Study Evaluating CCI-779 in Active Rheumatoid Arthritis on Concomitant Methotrexate TherapyTerminatedNCT00076206Phase 2
- CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00075647Phase 2
- Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine TumorsCompletedNCT00075439Phase 2
- Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube CancerCompletedNCT00074867Phase 2
- A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 Given In Combination With ChemotherapyCompletedNCT00074854Phase 1/2
- Study Evaluating EKB-569 in Advanced Colorectal CancerCompletedNCT00072748Phase 2
- Erlotinib (Tarceva (Trademark), OSI-774) in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00072631Phase 2
- Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid TumorsCompletedNCT00072436Phase 1
- Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00072072Phase 1
- Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)CompletedNCT00071994Phase 2
- Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of RelapseCompletedNCT00071968Phase 2
- ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)CompletedNCT00071188Phase 2
- Alvocidib in Treating Patients With Metastatic or Unresectable Refractory Solid Tumors or Hematologic MalignanciesTerminatedNCT00070239Phase 1
- S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell CancerCompletedNCT00068783Phase 2
- Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung CancerCompletedNCT00068653Phase 2
- Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung CancerCompletedNCT00068497Not applicable
- Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's LymphomaTerminatedNCT00068302Phase 1
- Study Evaluating EKB-569 in Advanced Non-Small Cell Lung CancerCompletedNCT00067548Phase 2
- Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast CancerCompletedNCT00066378Phase 2
- Gefitinib in Treating Patients With Metastatic Breast Cancer That Has Progressed After Antiestrogen and Nonsteroidal Aromatase Inhibitor TherapyCompletedNCT00066339Phase 2
- Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous LeukemiaCompletedNCT00066326Phase 1
- ZD6474 in Treating Patients With Small Cell Lung CancerCompletedNCT00066313Phase 2
- Safety and Tolerance Study of Oral Doses of CT53518 to Treat Patients With Acute Myelogenous Leukemia (AML)CompletedNCT00064584Phase 1
- Perifosine in Treating Patients With Advanced Soft Tissue SarcomaCompletedNCT00064324Phase 2
- Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic CancerCompletedNCT00064285Phase 1
- BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib MesylateCompletedNCT00064233Phase 1
- Erlotinib, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic CancerCompletedNCT00063947Phase 1
- Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and NeckCompletedNCT00063895Phase 1/2
- GW572016 For Treatment Of Refractory Metastatic Breast CancerCompletedNCT00062686Phase 2
- Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck CancerTerminatedNCT00062387Phase 2
- Neoadjuvant Chemoradiotherapy With or Without Gefitinib in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung CancerCompletedNCT00062270Phase 1/2
- Imatinib Mesylate in Treating Patients With Recurrent Ewing's Family of Tumors or Desmoplastic Small Round-Cell TumorCompletedNCT00062205Phase 2
- Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal CancerTerminatedNCT00062023Phase 2
- Improving Immunosuppressive Treatment for Patients With Severe Aplastic AnemiaCompletedNCT00061360Phase 2
- Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)CompletedNCT00060645Phase 1
- Safety Study of Ridaforolimus in Patients With Advanced, Refractory or Recurrent Malignancies (MK-8669-001 AM5)(COMPLETED)CompletedNCT00060632Phase 1
- Perifosine in Treating Patients With Metastatic, Androgen-Independent Prostate CancerCompletedNCT00060437Phase 2
- A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal CancerCompletedNCT00060411Phase 1
- Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell CancerCompletedNCT00060307Phase 2
- GW786034 in Treating Patients With Advanced Solid TumorsCompletedNCT00060151Phase 1
- Perifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic CancerCompletedNCT00059982Phase 2
- Erlotinib and Gemcitabine in Treating Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline and/or a TaxaneCompletedNCT00059852Phase 2
- A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell CarcinomaCompletedNCT00059735Phase 2
- This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC.CompletedNCT00059722Phase 2
- Bryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell TransplantationCompletedNCT00058305Phase 2
- Genistein in Treating Patients With Localized Prostate Cancer Who Are Planning to Undergo Radical ProstatectomyTerminatedNCT00058266Phase 2
- Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell LymphomaCompletedNCT00058227Phase 1
- Treatment With SU11248 in Patients With Neuroendocrine TumorsCompletedNCT00056693Phase 2
- Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.CompletedNCT00056459Phase 3
- Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal CancerCompletedNCT00056446Phase 3
- EYE001 to Treat Retinal Tumors in Patients With Von Hippel-Lindau SyndromeCompletedNCT00056199Phase 1